Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)

The summary for the Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed): Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This NOFO seeks to address both challenges simultaneously by having two equally important goals: entrepreneurial mentoring support, and product development support.
Federal Grant Title: Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Education, Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-24-023
Type of Funding: Grant
CFDA Numbers: 93.172, 93.242, 93.286, 93.394
CFDA Descriptions: Information not provided
Current Application Deadline: August 21st, 2024
Original Application Deadline: August 21st, 2024
Posted Date: April 23rd, 2024
Creation Date: April 23rd, 2024
Archive Date: September 26th, 2024
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: April 23rd, 2024
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-023.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical,...
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not All...
Women's Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial...
The Road to Prevention of Stillbirth Clinical Research Centers (UG1 Clinical Trial Option...
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk...
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com